key: cord-0847978-3civclkm authors: Santhi, Veerasamy Pushparaj; Masilamani, Poomaruthai; Sriramavaratharajan, Venkatraman; Murugan, Ramar; Gurav, Shailendra S.; Sarasu, Veerasamy Pushparaj; Parthiban, Subbaiyan; Ayyanar, Muniappan title: Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections date: 2021-07-08 journal: J Food Biochem DOI: 10.1111/jfbc.13851 sha: a3c3fa81df6005ad45a97cd5bc02bf84410633e2 doc_id: 847978 cord_uid: 3civclkm Plant‐derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, α‐mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiting viral replication against IFV, DENV, polio, CHIKV, Zika, HIV, HSV, HBV, HCV, and SARS‐CoV. The significance of edible fruit phytochemicals to block the virulence of various deadly viruses through their inhibitory action against the entry and replication of viral genetic makeup and proteins are discussed. In view of the antiviral property of active constituents of edible fruits which can strengthen the immune system and reduce oxidative stress, they are suggested to be diet supplements to combat various viral diseases including COVID‐19. PRACTICAL APPLICATIONS: Considering the increasing threat of COVID‐19, it is suggested to examine the therapeutic efficacy of existing antiviral molecules of edible fruits which may provide prophylactic and adjuvant therapy with their potential antioxidant, anti‐inflammatory, and immune‐modulatory effects. Several active molecules like geraniin, naringenin, (2R,4R)‐1,2,4‐trihydroxyheptadec‐16‐one, betacyanins, mangiferin, punicalagin, isomangiferin, procyanidin B2, quercetin, marmelide, jacalin lectin, banana lectin, and α‐mangostin isolated from various edible fruits have showed promising antiviral properties against different pathogenic viruses. Especially flavonoid compounds extracted from edible fruits possess potential antiviral activity against a wide array of viruses like HIV‐1, HSV‐1 and 2, HCV, INF, dengue, yellow fever, NSV, and Zika virus infection. Hence taking such fruits or edible fruits and their constituents/compounds as dietary supplements could deliver adequate plasma levels in the body to optimize the cell and tissue levels and could lead to possible benefits for the preventive measures for this pandemic COVID‐19 situation. Viruses are one of the major causes of morbidity and mortality around the world that affect about five million people annually (Andersen et al., 2020) . There is an ever increase in the number of cases of human immunedeficiency virus, influenza, hepatitis C virus, and herpes simplex viruses which are leading causes of morbidity and death in human (Khwaza et al., 2018) . The respiratory tract infections caused by different viral pathogens especially influenza viruses are considered a critical public health issue and causing millions of deaths worldwide annually, particularly with lower respiratory tract infections (Farrag et al., 2019) . To overcome this, novel molecules of natural products which hold effective therapeutic potential against such viral diseases are the prime focus to prevent the widespread infections and identification of antiviral mechanisms from these drugs is attracted the researchers throughout the World (Patel et al., 2021) . Many viral diseases have so far been emerged from different parts of the world. Most of these viral diseases are infectious and pose continuous challenge that can emerge or re-emerge at unpredictable times in diverse climatic conditions. An emerging viral disease is broadly referred as one of the newly evolved infectious disease or recently recognized or have not been witnessed earlier within a specific population or geographical region (Gedif Meseret, 2020) . Smallpox emerged from Asia and spread to Europe in 5th century, yellow fever emerged from America during the 16th century, dengue fever from South-east Asia, Africa, and North America during the 18th century, Spanish flu during 1918-1919 in almost all countries which killed about 40 million people and HIV originated from Africa in the second half of the 20th century which kills nearly 300,000 people every year (Chastel, 2007) . Since 1980s, the world has frequently been facing newly developed/formed pandemic viral infections which continue as a major threat to the human population. In the late 1990s, a highly pathogenic and deadly avian influenza A virus (H5N1) with several subtypes like H7N9, H9N2, and H7N3 spread from poultry to human which becomes a pandemic disease (Luo (George) & Gao, 2020) . Nipah virus (paramyxovirus) has been identified as a major cause of severe encephalitis in South-east Asian countries (Chua, 2000) . Severe acute respiratory syndrome (SARS), a respiratory disease caused by a novel coronavirus (SARS-CoV) was first identified from China in early 2000 that affected people in 37 countries with over 8,000 infections and 774 deaths (Fouchier et al., 2003) . (Baseler et al., 2017; Bogoch et al., 2016; Vijaykrishna et al., 2010; Yu et al., 2011; Zumla et al., 2015) . Of these, SARS-CoV and MERS-CoV are caused by the coronaviruses, the major pathogens which target the primary respiratory system in humans and pose severe threat during the last two decades. The SARS-CoV-2 is transmitted from human to human by respiratory droplets, close contact with diseased persons, and possibly by oral and aerosol contact of diseased patients and airborne transmission is extremely virulent and represents a foremost route to spread of disease (dos Santos, 2020) . The major routes of transmission of virus are reported by new infections within the family members, health care workers, and small to larger communities. Because of rapid spread and nature of transmission, the WHO declared the COVID-19 as a pandemic disease with public health emergency of international concern (Chikhale et al., 2020; Walls et al., 2020) . The common symptoms of COVID-19 in humans include fever, cough, dyspnea (shortness of breath), and in severe cases, the infection causes SARS, kidney failure, and pneumonia which leads to death (Xian et al., 2020) . Like SARS-CoV, the SARS-Cov-2 affects the elderly people with underlying comorbidities and cause complications with bilateral interstitial pneumonia, acute respiratory distress syndrome, acute cardiac injury, and secondary super-infections (Liu et al., 2020) . The potential cellular and molecular level pathogenesis of SARS-CoV-2 and its mechanisms responsible for different malfunctions in the body are still unidentified (Filardo et al., 2020) . The recent pieces of evidence prove that the spike glycoproteins of SARS-CoV-2 have structural similarity to the SARS-CoV Walls et al., 2020) . The foremost step and important phenomenon in the coronavirus infection is a viral entry into the host cell (interaction of host cell through viral spike protein) followed by replication and spread into healthy cells. The natural therapeutic agents which block the entry of viral DNA/RNA can be considered as potential antiviral therapeutics (Sayed et al., 2020; Zahedipour et al., 2020) . There are many resemblances between the genetic makeup of MERS-CoV, SARS-CoV, and SARS-CoV-2 (all three belong to a β-coronavirus family with ssRNA, closer genome sequence homology, and almost same pathogenesis mechanism) and existing plant-based antiviral therapies used the cell and tissue levels and could lead to possible benefits for the preventive measures for this pandemic COVID-19 situation. COVID-19, immune-modulators, phytochemicals, therapeutics, viral replication for SARS-CoV can also be examined against the COVID-19 (Bhuiyan et al., 2020) . With the speedy spread of COVID-19, it is considered a major alarming threat for almost all the countries and there is an increased demand to carry out extensive research in developing effective vaccines or antiviral agents against the various strains of coronaviruses (Bhuiyan et al., 2020) . The currently available drugs which are effective against some of the coronavirus strains can also be used against COVID-19, but this is not the perfect solution to overcome this pandemic situation (Wilder-Smith et al., 2020). Natural products have made great contributions to human health. Since ancient times, natural products from plant resources are used in treating various diseases including viral infections. Subsequently, many active constituents have been identified, isolated and their mechanisms of action in host organism have been elucidated by various researchers (Liu & Du, 2012) . Plants have the potential to produce diverse secondary metabolites and maintain human health by inhibiting virus attachment, penetration, replication, and interfering intracellular signal activation pathways. So, it is essential to develop potential antiviral agents from natural products that have been traditionally used as antiviral agents which can be expected to prolong the efficacy of drug therapy. Although the antiviral activity of several natural products against various infectious viruses has been investigated, there is a lacuna in the development of natural drugs as antiviral therapies against the coronaviruses which cause many diseases like bronchitis, gastroenteritis, hepatitis, pneumonia and leads to death in birds, bats, cats, and humans (Denaro et al., 2020; Islam et al., 2020) . There are several classes of phytochemicals present in various parts of plants which are reported to have many active principles with antiviral activity (Ghildiyal et al., 2020) . The phytochemicals like phenolic compounds, alkaloids, flavonoids, saponins, quinines, tannins, terpenes, proanthocyanidins, proanthocyanins, lignins, glycosides, steroids, organic acids, coumarins thiosulfonates with a broad spectrum of pharmacokinetics, are reported to have antiviral activity (Chukwu Odimegwu & Gospel Ukachukwu, 2020; Liu & Du, 2012 (Ben-Shabat et al., 2020) . The mechanism of action of these antiviral compounds is also well addressed. In the last few decades, the success of plant-based effective therapies led to much attention in the identification of antiviral lead molecules of plant origin (Lee et al., 2013) . With the continuous search on antiviral agents, plant-based natural compounds such as caffeic acid, griffithsin, isobavachalcone, myricetin, psoralidin, quercetin, saikosaponin B2, scutellarein, silvestrol, and tryptanthrin showed promising results against the deadly viruses like coronaviruses in humans (Mani et al., 2020; Sinha et al., 2020) . Research on antiviral agents from plant extracts has gained momentum since 1950s when some of the traditional medicinal plants have proven effective against some pathogenic viruses. Antiviral synthetic medicines administered for exterminating these infectious viruses also impose side effects on human health thus demanding intervention of antiviral agents of plant origin. Post-exposure of human system to different viral infections requires effective therapeutic approaches to overcome severe infections and it is vital to develop novel antiviral agents from natural products (Chukwu Odimegwu & Gospel Ukachukwu, 2020) . Plant-derived bioactives display antiviral activity against the SARS viral targets including mode of viral entry and viral replication into host cells (Sayed et al., 2020) . Given the facts of the ability of edible fruit constituents in improving body immunity, we have tried to consolidate previously published data on such research with antiviral potential. The objective of this review was to gather information on antiviral properties of bioactive constituents isolated from edible fruits, and efforts to obtain their efficient delivery. Since secondary metabolites of edible fruits are reported to possess antiviral properties, these can also be utilized in combating COVID-19 in the current pandemic situation. Several online bibliographical databases including PubMed, Scopus, and Web of Science were used to search literature on the antiviral effect of edible fruit constituents. An extensive literature search was conducted in the above databases with the terms "edible fruits and phytoconstituents", edible fruit constituents, "antiviral activity" along with "viral infections", "viral replication", "immunomodulators", and "immune boosters". Only the reports that were in English were considered and included while compiling the data. The related articles linked to the retrieval list of articles were autoprompted during the literature search and reviewed for relevance. The references cited in the retrieved articles were also searched to get further results. Chemical structures of compounds were drawn using ACD/ChemSketch software (ACD/Labs Release 2012, File version 14.01, Build 65,894). Bioactive constituents like flavonoids and polyphenols extracted from various fruits shown to alleviate an inflammatory response in adipocytes, macrophages, and other immune cells and improve several metabolic disorders by modulating their mechanism . Among the reported phytochemicals from edible fruits, phenolic compounds were extensively studied to reduce the risk of life-threatening diseases like cancer, heart problem, and diabetes along with antimicrobial, antiviral, anti-inflammatory, and antiallergenic properties (Shahidi & Ambigaipalan, 2015) . Several plants of nutraceutical significance and their phytochemicals are reported to be effective against diverse viral respiratory infections and altered the immune stimulation and inflammation modulating effects (Patel et al., 2021) . Due to the revival of interest in herbal medicines and novel compounds of nutraceutical plants, the AYUSH (https://www.ayush.gov.in/) systems of medicine promote lifestyle modification and dietary management in day-to-day life in the prevention of COVID-19 by improving immunity in the body. Antioxidants present in edible fruits can scavenge reactive oxygen species and inhibit the NF-kB-mediated inflammation which leads to inhibit oxidative stress (Wood & Gibson, 2009 ). The excess amount of free radicles produced in the body by various factors could cause oxidative stress which leads to chronic diseases, so the increased consumption of edible fruits with a rich amount of antioxidants in the daily diet will prevent or slow down the oxidative stress (Sun et al., 2002) . Several flavonoid compounds extracted from edi- The phytochemicals tested for antiviral activity are abundant in various nuts, fruits, berries, and its active components possibly have the capacity to diminish infection and replication of many viruses (Brijesh et al., 2009 ). The review also provided an overview of likely effects of the intake of edible fruits constituents to strengthen the immune cells by reducing the oxidative stress in host body system which in turn inhibit the viral attachment and replication on the host cell. Several active molecules from the fruits like geraniin from rambutan, naringenin from citrus and grapes, (2R,4R)-1,2,4-trihydroxyheptadec-16-one from avocado, betacyanin from red dragon, mangiferin and isomangiferin from mango, procyanidin B2 and quercetin from apple, punicalagin from pomegranate, marmelide from bael, jacalin lectin from jackfruit, and a banana lectin from banana have been isolated and showed promising antiviral properties against different pathogenic viruses ( Table 1) to 80% by blocking the infectivity of the NSV (Paredes et al., 2003) . The HCV is the foremost cause for chronic liver diseases associated with circulating lipoproteins, cholesterol, and lipid pathways and it progresses to a chronic state in about 70% of patients, ultimately causing cirrhosis and hepatocellular carcinoma (Nahmias et al., 2008) . Their study also suggested to take naringenin as HIV-1 Significant inhibitory effect against the replication of HIV-1 showed with IC 50 and EC 50 of 1.8 ± 0.5 µg/ml and 0.24 ± 0.10 µg/ml respectively in MAGI cells Notka et al. (2003) The significant anti-HIV activity was recorded in CD4+ lymphoid cells MT4 at even low concentrations Notka et al. (2003) Punicalagin EV71 Viral replication was inhibited with reduced cytopathic effect on rhabdomyosarcoma cells HSV-1 Viral infectivity and replication were reduced 8-fold with no toxicity and assembly very-low-density lipoprotein (VLDL) in host cells especially in human hepatocytes (Huang et al., 2007) . The Huh-7.5.1 cells infected with HCV administered with 200 μM naringenin for 24 hr inhibits the secretion of HCV core and HCV positive-strand RNA followed by inhibition of apoB100-dependent HCV secretion in a dose-dependent manner (Nahmias et al., 2008) . Naringenin obtained from grapefruit [Vitis vinifera L., Vitaceae] repressed VLDL secretion, microsomal triglyceride transfer protein activity, and transcription of 3-hydroxy-3-methyl-glutarl-coenzyme A reductase and acyl-coenzyme A cholesterol acyl-transferase leading to a reduction in 80% of HCV by silencing the apoB mRNA in infected cells and caused a 70% reduction in the release of apoB100 as well as HCV replication (Nahmias et al., 2008) . Naringenin obtained from the grapefruit significantly inhibited the secretion of apoB and HCV RNA followed by a decreased level of HCV core protein secretion (Goldwasser et al., 2011) . Naringenin Mangiferin ( (Guha et al., 1996) . Mangiferin purified from the root and rhizome extracts of anemarrhena (Anemarrhena asphodeloides Bunge, Asparagaceae) exhibited dose-dependent anti-HIV inhibitory activity on HIV-1 induced syncytium formation in HIV-1 IIIB and HIV-1 RF with the EC 50 of 7.13 μg/ml (16.90 μM) and 15.45 μg/ml (36.61 μM) respectively . In the time-of-addition assay, when mangiferin was added at various times after HIV-1 IIIB infected C8166 cells, the compound blocked HIV-1 p24 antigen production after 12 hr. It is also observed that mangiferin is effective against HIV-1 peptidic protease inhibitor-resistant strains and less effective against the protease inhibitor-resistant strains of HIV-1. Mangiferin isolated from the fruit peels of mango showed good inhibitory property against poliovirus-1 with 97.8%, 84.2%, and 57.1% of viral inhibition at 200, 100, and 50 μg/ml concentrations, respectively (Rechenchoski et al., 2018) . The overall IC 50 was recorded as 53.5 μg/ml and after 12 hr of mangiferin treatment 62.7% of viral inhibition was recorded at the concentration of 100 μg/ml. However, during the late stages of viral replication, even at a low concentration (25 μg/ml) mangiferin exhibited strong virucidal activity with 100% of viral inhibition of viral adsorption. The α-mangostin (Figure 1d ) is the major xanthone extracted from the pericarps and bark of the mangosteen (Garcinia mangostana L., Clusiaceae) and holds a wide range of biological activities such as antimicrobial, antiparasitic, antioxidant, anti-inflammatory, anti-tumor, antiobesity, cardioprotective, and antidiabetic (Ibrahim et al., 2016) . This xanthone compound showed noteworthy pharmacological effects in in vitro studies as well as in experimental animal models through various mechanisms of action. The ethanolic extract of mangosteen fruit is considered as a potent inhibitor of HIV-1 protease activity and the antiviral property of this fruit is due to the presence of purified molecules like α-mangostin and γ-mangostin (Chen et al., 1996) . The administration of α-mangostin (obtained from the pericarps of mangosteen) to dengue patients during the acute phase of illness may decrease infection severity by activating the host's immune response through mechanism of interfering DENV NS5 protein activity which is essential for DENV replication and reducing transcriptional responses of cytokines (Sugiyanto et al., 2019) . The effect of α-mangostin against the DENV infection and postinfection in PBMCs, TNFα and IFNγ cytokines revealed that increasing concentration of α-mangostin inhibits the viral replication by more than 50% with the IC 50 of 5.47 and 5.77 μM for 24 and 48 hr of post-treatments, respectively (Sugiyanto et al., 2019) . The α-mangostin inhibits DENV production in cultured hepatocellular carcinoma HepG2 and Huh-7 cells, and cytokine/chemokine expression in HepG2 cells (Tarasuk et al., 2017) . DENV virus-infected cells treated with α-mangostin considerably reduced the infection rates 47%-55%, and complete inhibition in production of DENV-1 and DENV-3 was recorded by decreasing the cytokine (IL-6 and TNFα) and chemokine (RANTES, MIP-1β, and IP-10) transcription. Therefore, α-mangostin can be considered as a potent antiviral agent than the synthetic ribavirin due to its superior activity. In the countries where all the four DENV serotypes are common which leads to severe secondary infections, α-mangostin is ideal and an effective antiviral drug (Sugiyanto et al., 2019) . In vitro prophylactic effect of α-mangostin (extracted from the pericarps of mangosteen) was significantly inhibited the replication of CHIKV in Vero E6 cells with the 100% reduction of virus titer at 8 μM concentration under cotreatment condition (Patil et al., 2021) . Also, reduction of CHIKV replication in serum and muscles of infected mice models showed nearly 99% of reduction in CHIKV RNA copies with low and high dose of α-mangostin. The molecular docking study revealed that α-mangostin interacts with the E2-E1 heterodimeric glycoprotein and the outcomes suggest that α-mangostin can possibly inhibit the replication of CHIKV infection through multiple target proteins (Patil et al., 2021) . Geraniin (Figure 1e) is an ellagitannin with a complex chemical structure belongs to a hydrolysable tannin group and commonly found in edible fruits like common berries (raspberries, strawberries, and blackberries), pomegranate, almonds, rambutan, and walnuts (Palanisamy et al., 2011) . Gareniin has a wide range of pharmacological activities and possesses antioxidant, antibacterial, antifungal, antitumour, antihypertensive, antinociceptive, radioprotective, and antiviral properties . Geraniin isolated from the rambutan [Nephelium lappaceum L., Sapindaceae] fruit rind reduces the infectivity of DENV-2, represses the viral attachment, and prevents DENV-2 replication upto 100% of inhibition during early stages of viral infection (Abdul Ahmad et al., 2017) . Geraniin effectively reduced the DENV-2 infectivity at 3.28 μM of concentration in a dose-dependent manner. It was also observed that the mechanism of geraniin is either through the binding or disruption to the DENV-E protein by inhibiting attachment of the virus to cellular receptors and binding of geraniin to E-DIII prevents protein-protein interaction between host cells and DENV-2 thus preventing viral attachment and entry of DENV into the host cells (Abdul Ahmad et al., 2017) . Geraniin produced a low cytotoxicity on human rhabdomyosarcoma cells in plaque reduction assay and addition of 20 μg/ml concentration of geraniin (with an IC 50 of 10 μg/ ml) at 2 hr post EV71 infection positively inhibited the infectious virus yield and viral RNA replication . In an in vivo study, the treatment of 0.4 and 1.0 mg/kg doses of geraniin significantly enhanced the survival rate of EV71 infected mice with 35% and 40%, respectively with a reduction in mortality and decreased viral replication in muscle tissues . Geraniin extracted from the whole plant parts of Phyllanthus urinaria L. [Phyllanthaceae] showed promising anti-HSV-1 and HSV-2 activity (Yang et al., 2007) . The compound efficiently inhibited the replication of HSV-2 with the IC 50 and IC 90 of 18.4 ± 2.0 µM and 37.6 ± 2.3 µM concentrations, respectively, and showed strong inhibitory effect against the replication of HSV-1 with the IC 50 of 35.0 ± 4.2 µM concentration of geraniin. The purified fraction of Phyllanthus emblica leaves enriched with geraniin showed significant inhibitory effect against the replication of HIV-1 with the IC 50 and EC 50 values of 1.8 ± 0.5 µg/ml (at a concentration of 1.9 ± 0.5 µM) and 0.24 ± 0.10 µg/ml (at a concentration of 0.25 ± 0.1 µM), respectively, in MAGI cells (Notka et al., 2003) . Likewise, geraniin showed decent anti-HIV-1 activity in the CD4+ lymphoid cells MT4 with the EC 50 and CC 50 values of 0.46 ± 0.17 µg/ml (0.48 ± 0.18 µM concentration) and 13.53 ± 2.30 µg/ml (14.20 ± 2.41 µM concentration) respectively. Punicalagin ( Figure 1f ) is a large polyphenolic compound which belongs to the hydrolysable tannins and identified as a major active constituent of pomegranate [Punica granatum L. Lythraceae] fruits especially in fruit rinds (Yang, Xiu, et al., 2012) . The compound is considered as potential free radical scavengers (antioxidant) which have superoxide anion, singlet oxygen, and hydroxyl radical scavenging abilities with lipid peroxidation inhibitory activity along with several health benefits (Kulkarni et al., 2007) . Punicalagin also possess a wide range of pharmacological effects including antimicrobial, antioxidant, chemo-preventive, hepatoprotective, immunestimulant, antiproliferative, apoptotic, and antiviral activities (Yang, Xiu, et al., 2012) . Punicalagin is the active anti-influenza component of the fruit rind extract of pomegranate which increases the inhibitory effect synergistically with oseltamivir by inhibiting the agglutination of chicken RBCs in the IFV-A (Haidari et al., 2009) . The compound also has the potential to inhibit the proliferation of IFV-A in both single and multiple cycle growth conditions in the infected MDCK cells. The in vitro and in vivo analysis on the antiviral effect of punicalagin (isolated from fruit rind extract of pomegranate) on EV71 showed that the compound decreases the cytopathic effect on rhabdomyosarcoma cells after treatment with 15 µg/ml of punicalagin at 2 hr post EV71 infection significantly inhibits the viral replication (Yang, Xiu, et al., 2012) . The punicalagin also impressively prolonged the survival time and reduced the mortality of mice models when administered with dose of 0.4, 1, or 5 mg/kg body weight which recorded 20, 40, and 38% of long-term survivor of infected mice. Punicalagin (extracted from fruit rind of pomegranate) at very low concentration shows a strong virucidal log reduction of 8.93 ± 0.35 (at 0.05 mg/ml concentration) on a mass to mass basis and reduces infectivity of the HSV-1 by inhibiting the viral replication in T75 of Vero cells infected with HSV-1 (Houston et al., 2017) . It was also observed that, when the punicalagin was added with ZnSO 4 at 0.14 mg/ml concentration it potentially increased the virucidal action with a resulting log reduction of 4.6 ± 0.16 mg/ ml from 2.4 ± 0.9 mg/ml. Punicalagin exhibits a strong anti-HSV-2 activity with 100% inhibition at 31.25 μg/ml and 50% of inhibition at 15.625 μg/ml in HEp-2 cells of human epithelial tissue-specific (Arunkumar & Rajarajan, 2018) . Liu et al. (2016) made an attempt to examine the anti-HBV activity of punicalagin through cell-based cccDNA (covalanetly closed circular DNA which formed from circular partially double-strand DNA) accumulation and stability assay in HepDES19 and HepG2.117 cell lines. Their study revealed that, punicalagin efficiently down regulated the level of cccDNA formation in HBV without inhibiting RNA transcription and DNA replication in host cells that indicates the role of punicalagin in cccDNA metabolism. The compound (2R,4R)-1,2,4-trihydroxyheptadec-16-one (THHY) extracted and purified from the unripe avocado [Persea americana Mill., Lauraceae] fruits possesses anti-DENV activity with the EC 50 of 14.61 ± 2.4, 10.98 ± 1.9, 12.87 ± 1.7, and 14.61 ± 2.1 µM on DENV-1, 2, 3, and 4 serotypes, respectively, with no observable cytotoxicity to host cell by stimulating the NF-κB-mediated IFN responses against the studied four serotypes (Wu et al., 2019) . THHY also prevents DENV replication in a time-dependent manner and treatment of virus-infected mice with THHY increased the survival rate ensuring that this fruit as a potential dietary resource to develop a supplement to treat DENV and related viral diseases. Lectins are principally proteins that bind to specific carbohydrate structures and different lectins isolated from plants, animals, fungi, and microbes are reported to be effective against HCV, influenza A/B, HSV-1 & 2, Japanese encephalitis virus, and coronaviruses with more focus on the anti-HIV property (Mazalovska & Kouokam, 2018) . In general, the lectins of plant origin encloses tandem repeats within the primary sequence and exist in the form of monomeric and higher multimeric states comprised of β-sheets (Mitchell et al., 2017) . In antiviral therapies, lectins can neutralize different viruses including influenza and HIV making them potential targets in developing novel antiviral drugs. As natural proteins, lectins target the sugar moieties of a SARS-CoV spike protein (glycoprotein) and primarily mannose binding lectins indicated their interference with virus attachment to SARS-CoV spike protein making them early entry inhibitors (Keyaerts et al., 2007) . The lectin (BanLec) isolated from the banana fruits [Musa acuminata Colla, Musaceae] is one of the jacalin-related (lectin isolated from Jackfruit) lectins which have the affinity towards highmannose structures. BanLec can inhibit various HIV-1 isolates in low nano-molar range with a concentration-dependent manner thus preventing the attachment of virus into host cell (Mazalovska & Kouokam, 2018) . BanLec is one of the potent mitogens form murine T-cells and when a mutation happens within sugar-binding site of BanLec, it reduces mitogenic activity without affecting HIV neutralization and mitogenicity, besides antiviral activities of BanLec requires association with N-glycans (Swanson et al., 2015) . The H84T BanLec, an engineered banana lectin is effective against an array of influenza virus strains that possesses significant antiviral activity better than most of the previously tested lectins (Covés-Datson et al., 2020) . The engineered lectin-like H84T BanLec is a broad-spectrum lectin capable of inhibiting both influenza A and B type viruses, which could be used as a potent therapeutic agent (Favero et al., 1993) . Lectin derived from jackfruit seeds inhibits HSV-2, VZV, and hCMV and shows mitogenic action for NK lymphocytes (CD16+/CD56+) (Wetprasit et al., 2000) . (Yingsakmongkon et al., 2008) . The concentrated fruit juice extract of Japanese Plum prevents and reduces the infectivity of human influenza A virus and it may be due to the presence of lectin-like compounds (with high molecular weight) which inhibits the attachment of viral hemagglutination on host cell surfaces. Betacyanin is a red-violet pigment belongs to betalains (pigments group) which are water-soluble, nitrogen containing pigments and can exist as the red-violet betacyanins or yellow betaxanthins (Gengatharan et al., 2015) . These groups of compounds are commonly available in several fruit crops like red dragon fruit, cacti fruit and also in red beetroot (as a red betacyanin and a yellow betaxanthin), various green amaranth species. Betacyanins extracted from various sources of fruits and other plant parts show a wide range of pharmacological effects including antioxidant, antibacterial, antifungal, anticancer, and antilipidemic activities (Gengatharan et al., 2015) . The betacyanin (Figure 1g) Cactaceae) shows a significant virucidal effect against the DENV-2 with 95% of inhibition at 379.5 µg/ml (with an IC 50 of 126.70 μg/ ml) without any cytotoxicity supporting its efficiency as a potential antiviral agent (Chang et al., 2020) . Their study on the virucidal effect of betacyanin fractions showed the ability of the compound to inactivate the extracellular DENV-2 particles and decrease the viral infection in dose-dependent manner. The exposure of CV-B3 to marmelide (Figure 1h ) isolated from the bael [Aegle marmelos Corr., Rutaceae] fruits causes a total loss of infectivity by inhibiting the formation of viral cells followed by the inactivation of viruses. The addition of marmelide at a concentration of 125 μg/ml for 1 hr on CV-B3 in Vero cells resulted in increased inhibition of infectivity that signifies the effect of the compound (Badam et al., 2002) . Therefore, marmelide could be a novel virucidal agent against the CV-B3 by further studying the mode of action by molecular level studies, since the mode of action marmelide could be associated with the earlier and later stages of virus replication in the host cell. Among the reported antiviral compounds of edible fruits, naringenin, mangiferin, and lectins are much effective against more number of viruses as reported by various researchers. Figure patients who are prone to depleted levels of antioxidants like vitamins, enzymes and some mineral elements (Muhammad et al., 2021) . Likewise, lectins of different plant origin (including edible fruits) interfere with the SARS-CoV glycoprotein during the initial entry and viral release into the host cell which piloted the further research on anti-SARS-CoV activity and anti-COVID-19 therapies using these plant lectins (Keyaerts et al., 2007) . Similarly, we hypothesized that EFCs may improve the immune system thereby suppress the COVID 19 infection, since antioxidants present in EFCs such as vitamin A, C, D, and E are reported to improve the immune response against COVID-19 (Khanna et al., 2021) . The overall recommendation of EFCs in COVID-19 treatment is due to their ability to improve the immune system as well as reducing the oxidative stress in the host cell machinery which helps to prevent the viral entry. As reported earlier, seasonal epidemics with coronavirus outbreaks like SARS-CoV and MERS CoV in the recent past and other major life threatening viral diseases like HCV and INF were successfully treated by various herbal drugs and phytoconstituents of nutraceuticals (Patel et al., 2021) . It was also advised that the prevention of viral respiratory related infections requires intake of vitamin C in the form of commercial drugs or regular consumption of fruits like orange, lemon, etc. which contains hesperidin as major compound (Bellavite & Donzelli, 2020) . Hence taking such fruits or EFCs as dietary supplements delivers adequate plasma levels in the body to optimize the cell and tissue levels which led to possible benefits for the preventive measures for this pandemic COVID-19 situation. The use of dietary supplements from various food sources and nutraceuticals as coadjutant therapeutics for the prevention and treatment of COVID-19 infection could be a useful strategy, since food-derived antioxidants has a key role in prevention of oxidative stress and inflammation which are plays a significant cause in the progression of COVID-19 (Lammi & Arnoldi, 2021) . The results of the recent studies also suggested that antioxidant rich vitamins like vitamin C and D are effectively activated the immune response which leads to reducing the risk of respiratory tract infections by noticeably balancing the inflammatory reaction which suggests the use of F I G U R E 2 Compounds isolated from edible fruits and its multi-target antiviral activity with a described mechanism. The different colored double arrow represents specific phytochemicals with respective antiviral properties with various actions in a host cell. LTN ( The manuscript does not have any data copied from other sources and the mechanism flowchart provided in the manuscript is drawn by us. The authors declared that they have no conflict of interest. The manuscript is a review article and do not need any ethical approval. https://orcid.org/0000-0003-4685-6376 Possible binding mechanism of constituents of edible fruit extracts against the COVID-19 virus. The figure depicts the regular intake of edible fruits and their constituents/compounds leads to strengthening the immune cells and reduces the oxidative stress in the host body system which in turn inhibits the viral attachment and replication on the host cell Lectins with anti-HIV activity: A review Quantitative analysis of rutin, quercetin, naringenin, and gallic acid by validated RP-and NP-HPTLC methods for quality control of anti-HBV active extract of Guiera senegalensis Discovery and development of safe-in-man broad-spectrum antiviral agents Study on antiviral activities, druglikeness and molecular docking of bioactive compounds of Punica granatum L. to Herpes simplex virus-2 (HSV-2) In vitro antiviral activity of bael (Aegle marmelos Corr) upon human coxsackieviruses B1-B6 The pathogenesis of Ebola virus disease Hesperidin and SARS-CoV-2: New light on the healthy function of citrus fruits Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies Plants metabolites: Possibility of natural therapeutics against the COVID-19 pandemic Anticipating the international spread of Zika virus from Brazil Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: Validating its traditional usage The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus Antiviral activity of betacyanins from red pitahaya (Hylocereus polyrhizus) and red spinach (Amaranthus dubius) against dengue virus type 2 (GenBank accession no. MH488959) Bulletin de l'Académie Nationale de Médecine Active constituents against HIV-1 protease from Garcinia mangostana Sars-cov-2 host entry and replication inhibitors from Indian ginseng: An in-silico approach Nipah virus: A recently emergent deadly paramyxovirus. Science (80-) Antiviral natural products against hepatitis-A virus A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo Antiviral activity of plants and their isolated bioactive compounds: An update Natural history of COVID-19 and current knowledge on treatment therapeutic options Epidemiology of respiratory viruses in Saudi Arabia: Toward a complete picture Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120 Therapeutic potential of resveratrol against emerging respiratory viral infections Koch's postulates fulfilled for SARS virus The citrus flavanone naringenin impairs dengue virus replication in human cells Emerging and re-emerging viral diseases: The case of coronavirus disease-19 (COVID-19) Betalains: Natural plant pigments with potential application in functional foods. LWT-Food Science and Technology Phytochemicals as antiviral agents: Recent updates Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism Orange juice as dietary source of antioxidants for patients with hepatitis C under antiviral therapy Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir Beneficial effects of naringenin in liver diseases: Molecular mechanisms Correction: Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins α-Mangostin from Garcinia mangostana Linn: An updated review of its pharmacological properties Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data In vitro antiviral activity of fisetin, rutin and naringenin against dengue virus type-2 Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle Antiviral activities of oleanolic acid and its analogues In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin Food-derived antioxidants and COVID-19 Reduction of hepatitis A virus on FRhK-4 cells treated with Korean red ginseng extract and ginsenosides Natural constituents from food sources as therapeutic agents for obesity and metabolic diseases targeting adipose tissue inflammation Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia Antiviral properties of phytochemicals Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV Health-promoting components of fruits and vegetables in the diet Functional foods and the immune system: A review Global health concerns stirred by emerging viral infections Natural product-derived phytochemicals as potential agents against coronaviruses: A review Lectins as promising therapeutics for the prevention and treatment of HIV and other potential coinfections Antiviral lectins: Selective inhibitors of viral entry Immune-boosting, antioxidant and antiinflammatory food supplements targeting pathogenesis of COVID-19 Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitorresistant variants by Phyllanthus amarus Rapid isolation of geraniin from Nephelium lappaceum rind waste and its anti-hyperglycemic activity Antisindbis activity of flavanones hesperetin and naringenin Therapeutic opportunities of edible antiviral plants for COVID-19 In vitro and in vivo studies reveal α-mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus Naringenin and quercetin -potential anti-HCV agents for NS2 protease targets Nature as a treasure trove of potential anti-SARS-CoV drug leads: A structural/mechanistic rationale Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects -A review Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: A pharmacoinformatics study Inhibitory effect of alpha-mangostin to dengue virus replication and cytokines expression in human peripheral blood mononuclear cells Antioxidant and antiproliferative activities of common fruits Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activity A lectin isolated from bananas is a potent inhibitor of HIV replication Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19 Reassortment of pandemic H1N1/2009 influenza A virus in swine Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains Jackfruit lectin: Properties of mitogenicity and the inhibition of herpesvirus infection Can we contain the COVID-19 outbreak with the same measures as for SARS? Dietary factors lead to innate immune activation in asthma Avocado (Persea americana) fruit extract (2R,4R)-1,2,4-trihydroxyheptadec-16-yne inhibits dengue virus replication via upregulation of NF-κB-dependent induction of antiviral interferon responses Bioactive natural compounds against human coronaviruses: A review and perspective The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-β-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection COVID-19: A new challenge for human beings Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo In vitro inhibition of human influenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume Sieb Fever with thrombocytopenia associated with a novel bunyavirus in China Potential effects of curcumin in the treatment of COVID-19 infection Antiviral potential of mangiferin against poliovirus Antiviral effect of mangiferin and isomangiferin on herpes simplex virus Antiviral activity of mangiferin against herpes simplex virus type 2 in vitro Middle East respiratory syndrome In vitro antiviral activity of fisetin, rutin and naringenin against dengue virus type-2 Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections